MaxCyte, Inc. (MXCT) Social Stream



MaxCyte, Inc. (MXCT): $4.73

-0.09 (-1.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About MXCT

$CYTH $MXCT $BYSI $ARCT the drug is a proprietary formulation of hydroxypropl-beta cyclodextrin with an affinity for cholesterol.

It's use in a cholesterol binding disease like NPC gives systemic treatment to every part of the body affected by the disease. And it crosses the BBB, giving affect to neurological systems as well.

Now let's say that the NPC drug was in the bag and the possibility of other cholesterol risk diseases is starting to appear on the table. Might be wise to get in sub $10 🤔 before this gets pumped by people who actually do it for a living.
diamondtoes, published August 5, 2021

What Else are MXCT Traders Talking About?


Other tickers frequently mentioned alongside MXCT are BYSI and ARCT.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3099 seconds.